Futoshi Saito Joins as President & General Manager, Japan BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) — Anaqua, the leading global innovation and intellectual property (IP) management technology provider, today announced changes to its executive leadership team in Japan as the company continues its strong growth trajectory in the country. Futoshi
Chris Caldwell NEWARK, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a leading global provider of customer experience (CX) services and technologies, today announced it has closed its combination with Webhelp and the integration of the two companies is underway. While the combined company finalizes its permanent
Former president of BlackRock, former CEO of NHSX, and former Director of GCHQ bring wealth of industry experience from finance, healthcare, and national security LONDON, Sept. 22, 2023 (GLOBE NEWSWIRE) — Quantexa, the global leader in Decision Intelligence (DI) solutions for the private and public sectors, announced today that it
Systems Integrator Partners Accenture, Aggne and Coforge; Solution Partners Copart, LexisNexis Risk Solutions, Quadient, and Smart Communications and Consulting Partner Penguin Tech are each recognized for meaningful technology innovations to the insurance industry during Duck Creek’s Partner Summit ’23 BOSTON, Sept. 21, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the
TAMPA, Fla., Sept. 20, 2023 (GLOBE NEWSWIRE) — WilsonHCG has been recognized as the No. 1 Recruitment Process Outsourcing (RPO) provider in HRO Today’s 2023 Baker’s Dozen List. The longest-standing customer satisfaction survey in the RPO industry, HRO Today’s Baker’s Dozen List is designed to highlight the world’s top RPO
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets. Zurich, Switzerland, Sept. 20, 2023 (GLOBE NEWSWIRE) — Acino, a Swiss pharmaceutical company headquartered in Zurich, today announced that it has entered into an agreement to acquire M8 Pharmaceuticals (M8),
